Global Retirement Partners’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
Other funds holding BBC
FDCDDQ
DWS
HI
BWP
Global Retirement Partners's BBC Position: Q3 2024 in Review
Global Retirement Partners sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2024, closing a stake of 44 shares — an estimated $1.11K sold.
Global Retirement Partners first reported a position in BBC in Q1 2018 and held it in 21 quarters. The position peaked at $21K in Q1 2021. 13 funds tracked by Wall St. Rank hold BBC as of Q3 2024.
- Global Retirement Partners reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2024 after selling out during the quarter.
- Global Retirement Partners sold 44 Virtus Biotech Clinical Trials ETF shares in Q3 2024, an estimated $1.11K.
- Global Retirement Partners first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2018 and held it in 21 quarters.
- Global Retirement Partners's Virtus Biotech Clinical Trials ETF position peaked at $21K in Q1 2021.
- 13 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2024.
Based on Global Retirement Partners's 13F filing for Q3 2024, filed 16 Oct 2024.